Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc H Scheetz

Showing results (211-220 of 222) with videos related to

Pageof 23
Sort By:
Pharmacotherapy|August 24, 2023
International consensus recommendations for the use of prolonged-infusion beta-lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists: An executive summaryLisa T Hong, Kevin J Downes, Alireza FakhriRavari, et al.
Pharmacotherapy|August 24, 2023
International consensus recommendations for the use of prolonged-infusion beta-lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases PharmacistsLisa T Hong, Kevin J Downes, Alireza FakhriRavari, et al.
Therapeutic Drug Monitoring|April 19, 2023
Why is the Implementation of Beta-Lactam Therapeutic Drug Monitoring for the Critically Ill Falling Short? A Multicenter Mixed-Methods StudyErin F Barreto, Pooja N Chitre, Kathleen H Pine, et al.
Microbiology Spectrum|December 12, 2024
Refined methodology for quantifying <i>Pseudomonas aeruginosa</i> virulence using <i>Galleria mellonella</i>Christopher M R Axline, Travis J Kochan, Sophie Nozick, et al.
Antimicrobial Agents and Chemotherapy|May 15, 2025
Individual target pharmacokinetic/pharmacodynamic attainment rates among cefepime-treated patients admitted to the ICU with hospital-acquired pneumonia with and without ECMOAdrian Valadez, Marta Zurawska, Emma Harlan, et al.
Antimicrobial Agents and Chemotherapy|December 29, 2025
Critical threshold target attainment rates for tazobactam combined with piperacillin among patients admitted to the ICU with hospital-acquired pneumoniaRyan Williamson, Marta Zurawska, Adrian Valadez, et al.
Antimicrobial Agents and Chemotherapy|December 29, 2025
Pharmacokinetic-pharmacodynamic target attainment with continuous infusion piperacillin in patients admitted to the ICU with hospital-acquired pneumoniaMarta Zurawska, Adrian Valadez, Emma Harlan, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 22, 2023
A population pharmacokinetic model of polymyxin B based on prospective clinical data to inform dosing in hospitalized patientsPatrick O Hanafin, Andrea Kwa, Alexandre P Zavascki, et al.
Antimicrobial Agents and Chemotherapy|June 4, 2026
Cefepime pharmacokinetics in critically ill children with multiple organ dysfunction syndrome using volumetric absorptive microsamplingVictor Amajor, Amanda Bwint, Steven L Shein, et al.
Clinical Pharmacology and Therapeutics|June 17, 2025
Population Pharmacokinetic/Toxicodynamic Model for Polymyxin B in Critically Ill Patients to Identify the Risk of NephrotoxicityPatrick O Hanafin, Ramya Mahadevan, Gauri G Rao, et al.
Pageof 23

Showing results (211-220 of 222) with videos related to

Sort By:
Pageof 23
Pharmacotherapy|August 24, 2023
International consensus recommendations for the use of prolonged-infusion beta-lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists: An executive summaryLisa T Hong, Kevin J Downes, Alireza FakhriRavari, et al.
Pharmacotherapy|August 24, 2023
International consensus recommendations for the use of prolonged-infusion beta-lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases PharmacistsLisa T Hong, Kevin J Downes, Alireza FakhriRavari, et al.
Therapeutic Drug Monitoring|April 19, 2023
Why is the Implementation of Beta-Lactam Therapeutic Drug Monitoring for the Critically Ill Falling Short? A Multicenter Mixed-Methods StudyErin F Barreto, Pooja N Chitre, Kathleen H Pine, et al.
Microbiology Spectrum|December 12, 2024
Refined methodology for quantifying <i>Pseudomonas aeruginosa</i> virulence using <i>Galleria mellonella</i>Christopher M R Axline, Travis J Kochan, Sophie Nozick, et al.
Antimicrobial Agents and Chemotherapy|May 15, 2025
Individual target pharmacokinetic/pharmacodynamic attainment rates among cefepime-treated patients admitted to the ICU with hospital-acquired pneumonia with and without ECMOAdrian Valadez, Marta Zurawska, Emma Harlan, et al.
Antimicrobial Agents and Chemotherapy|December 29, 2025
Critical threshold target attainment rates for tazobactam combined with piperacillin among patients admitted to the ICU with hospital-acquired pneumoniaRyan Williamson, Marta Zurawska, Adrian Valadez, et al.
Antimicrobial Agents and Chemotherapy|December 29, 2025
Pharmacokinetic-pharmacodynamic target attainment with continuous infusion piperacillin in patients admitted to the ICU with hospital-acquired pneumoniaMarta Zurawska, Adrian Valadez, Emma Harlan, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 22, 2023
A population pharmacokinetic model of polymyxin B based on prospective clinical data to inform dosing in hospitalized patientsPatrick O Hanafin, Andrea Kwa, Alexandre P Zavascki, et al.
Antimicrobial Agents and Chemotherapy|June 4, 2026
Cefepime pharmacokinetics in critically ill children with multiple organ dysfunction syndrome using volumetric absorptive microsamplingVictor Amajor, Amanda Bwint, Steven L Shein, et al.
Clinical Pharmacology and Therapeutics|June 17, 2025
Population Pharmacokinetic/Toxicodynamic Model for Polymyxin B in Critically Ill Patients to Identify the Risk of NephrotoxicityPatrick O Hanafin, Ramya Mahadevan, Gauri G Rao, et al.
Pageof 23